US CDC: Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19
#1

During the Omicron-predominant period, VE against COVID-19–associated ED/UC encounters was lower overall compared with that during the Delta-predominant period and waned after the second dose, from 69% within 2 months of vaccination to 37% at ≥5 months after vaccination (p<0.001).

Protection increased after a third dose, with VE of 87% among those vaccinated within the past 2 months; however, VE after 3 doses declined to 66% among those vaccinated 4–5 months earlier and 31% among those vaccinated ≥5 months earlier, although the latter estimate is imprecise because few data were available on persons vaccinated for ≥5 months after a third dose. The decreasing trend of VE with increasing time since vaccination was significant (p<0.001).

https://www.cdc.gov/mmwr/volumes/71/wr/mm7107e2.htm
[+] 1 user Likes theold's post
Reply


Forum Jump:


Users browsing this thread: 1 Guest(s)